Bo Lu, MD

Contact Dr. Lu

G-301 Bodine Cancer Center
111 S. 11th Street
Philadelphia, PA 19107

(215) 955-6705
(215) 503-0013 fax

Most Recent Peer-reviewed Publications

  1. The Underappreciated Role of the Humoral Immune System and B Cells in Tumorigenesis and Cancer Therapeutics: A Review
  2. Disparity in age at lung cancer diagnosis between current and former smokers
  3. SMac mimetic Debio 1143 and ablative radiation therapy synergize to enhance antitumor immunity against lung cancer
  4. Combining radiation and immune checkpoint blockade in the treatment of head and neck squamous cell carcinoma
  5. Neoadjuvant PD-1 blockade in non-small cell lung cancer: What else do we need to do?
  6. Targeting Myeloid-derived Suppressor Cells and Programmed Death Ligand 1 Confers Therapeutic Advantage of Ablative Hypofractionated Radiation Therapy Compared With Conventional Fractionated Radiation Therapy
  7. Blockade of Tumor-Expressed PD-1 promotes lung cancer growth
  8. PD-1 Modulates Radiation-Induced Cardiac Toxicity through Cytotoxic T Lymphocytes
  9. Beyond concurrent chemoradiation: The emerging role of PD-1/PD-L1 inhibitors in stage III lung cancer
  10. Utility of stereotactic ablative radiotherapy/stereotactic body radiation therapy in the setting of oligometastatic non-small cell lung cancer
  11. Decreased Survival After Combining Thoracic Irradiation and an Anti-PD-1 Antibody Correlated With Increased T-cell Infiltration Into Cardiac and Lung Tissues
  12. IGFBP3 modulates lung tumorigenesis and cell growth through IGF1 signaling
  13. Comparison of Online 6 Degree-of-Freedom Image Registration of Varian TrueBeam Cone-Beam CT and BrainLab ExacTrac X-Ray for Intracranial Radiosurgery
  14. Neutrophil to lymphocyte ratio associated with prognosis of lung cancer
  15. Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non–Small-Cell Lung Cancer (RTOG 3505)
  16. siRNA-Encapsulated Hybrid Nanoparticles Target Mutant K-ras and Inhibit Metastatic Tumor Burden in a Mouse Model of Lung Cancer
  17. Brigatinib and the new generation of ALK-inhibitors for non-small cell lung cancer
  18. Debio-1143: Inhibitor of apoptosis protein (IAP) antagonist Cancer therapy
  19. Stereotactic Body Radiation Therapy Delivery in a Genetically Engineered Mouse Model of Lung Cancer
  20. Immune biomarkers of treatment failure for a patient on a phase i clinical trial of pembrolizumab plus radiotherapy
  21. Nitrilase 1 modulates lung tumor progression in vitro and in vivo
  22. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
  23. Lung cancer screening: Not all nodules are created equal
  24. Systemic therapy for echinoderm microtubule-associated proteinlike 4 anaplastic lymphoma kinase non-small cell lung cancer brain metastases
  25. Biodistribution and Pharmacokinetics Study of siRNA-loaded Anti-NTSR1-mAb-functionalized Novel Hybrid Nanoparticles in a Metastatic Orthotopic Murine Lung Cancer Model